3 results

• Eli Lilly Claims Kisunla Brain Swelling Side Effects Can Be Reduced With Modified Dosing Schedule

  November 4, 2024

  Irvin Jackson

  Makers of the new Alzheimer's disease drug Kisunla have developed a new dosing schedule, which may reduce the risk of brain swelling.

• Eisai Never Told Patients in Leqembi Clinical Trials They Faced Higher Risk of Brain Bleeds: NYT

  October 25, 2024

  Martha Garcia

  New York Times investigative report reveals that the manufacturer of the Alzheimer’s disease drug Leqembi failed to inform test subjects that they had genetic markers making them more susceptible to brain bleeds and death if they took the medication.

• Alzheimer’s Disease Drugs Aduhelm, Leqembi May Cause Brain Shrinkage: Study

  April 19, 2023

  Martha Garcia

  A new study warns that Aduhelm and Leqembi, new Alzheimer's disease drugs, may cause brain shrinkage which accelerates the condition instead of treating it.